These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6429677)

  • 21. Action of the benzodiazepine antagonist Ro 15-1788 in humans after sleep withdrawal.
    Emrich HM; Sonderegger P; Mai N
    Neurosci Lett; 1984 Jun; 47(3):369-73. PubMed ID: 6433243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative pharmaco-electroencephalographic differentiation between the CNS effects of bromocriptine and imipramine, drugs with qualitatively different antidepressant properties.
    Yamadera H; Ferber G; Matejcek M; Pokorny R
    Pharmacopsychiatry; 1987 Mar; 20(2):54-9. PubMed ID: 3588662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepine antagonist Ro 15-1788 in self-poisoning. Diagnostic and therapeutic use.
    Hofer P; Scollo-Lavizzari G
    Arch Intern Med; 1985 Apr; 145(4):663-4. PubMed ID: 2859006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
    Steindl P; Püspök A; Druml W; Ferenci P
    Hepatology; 1991 Dec; 14(6):963-8. PubMed ID: 1660024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First clinical investigation of the benzodiazepine antagonist Ro 15-1788 in comatose patients.
    Scollo-Lavizzari G
    Eur Neurol; 1983; 22(1):7-11. PubMed ID: 6132818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788.
    Darragh A; Lambe R; O'Boyle C; Kenny M; Brick I
    Psychopharmacology (Berl); 1983; 80(2):192-5. PubMed ID: 6410450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurophysiological monitoring (electroencephalogram, evoked potentials) and the effects of benzodiazepines].
    Kochs E; Schulte am Esch J
    Anasth Intensivther Notfallmed; 1988 Jun; 23(3):145-52. PubMed ID: 2899984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans.
    Klotz U; Ziegler G; Ludwig L; Reimann IW
    J Clin Pharmacol; 1985 Sep; 25(6):400-6. PubMed ID: 2865275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.
    Higgitt A; Lader M; Fonagy P
    Psychopharmacology (Berl); 1986; 89(4):395-403. PubMed ID: 3092269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of benzodiazepines on interneuronal transmission in afferent systems and their antagonism with Ro 15-1788].
    Kharkevich DA; Sinitsyn LN; Churiukanov VV; Fisenko VP; Chichenikov ON
    Farmakol Toksikol; 1983; 46(5):14-9. PubMed ID: 6138277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between plasma-levels of chlorpromazine and effects on EEG and evoked potentials in healthy volunteers.
    Laurian S; Le PK; Baumann P; Perey M; Gaillard JM
    Pharmacopsychiatria; 1981 Nov; 14(6):199-204. PubMed ID: 7323140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.
    Darragh A; Lambe R; Kenny M; Brick I; Taaffe W; O'Boyle C
    Br J Clin Pharmacol; 1982 Nov; 14(5):677-82. PubMed ID: 6814472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of visual function in healthy subjects after administration of Ro 15-1788.
    Lupolover Y; Safran AB; Desangles D; de Weisse C; Meyer JJ; Bousquet A; Assimacopoulos A
    Eur J Clin Pharmacol; 1984; 27(4):505-7. PubMed ID: 6440793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anticonvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases.
    Scollo-Lavizzari G
    Eur Neurol; 1984; 23(1):1-6. PubMed ID: 6425066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of RO 15-1788 and RO 5-4684 on the evoked activity of neurons in hippocampal sections].
    Glushakov PG
    Biull Eksp Biol Med; 1987 Dec; 104(12):687-90. PubMed ID: 3120818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.
    File SE; Pellow S
    Psychopharmacology (Berl); 1986; 88(1):1-11. PubMed ID: 3003778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.
    Gentil V; Tavares S; Gorenstein C; Bello C; Mathias L; Gronich G; Singer J
    Psychopharmacology (Berl); 1990; 100(1):54-9. PubMed ID: 2104987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benzodiazepine (+)-tifluadom (KC-6128), but not its optical isomer (KC-5911) induces opioid kappa receptor-related EEG power spectra and evoked potential changes.
    Freye E; Boeck G; Schaal M; Ciaramelli F
    Pharmacology; 1986; 33(5):241-8. PubMed ID: 3025899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contralateral eye movements and alpha reactivity of lithium patients in recognition tasks.
    Opgenoorth E; Wolf R; Presslich O; Anderer P
    Pharmacopsychiatry; 1987 Sep; 20(5):208-12. PubMed ID: 3671490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.